258 related articles for article (PubMed ID: 25405367)
1. Role of the staphylococcal nuclease and tudor domain containing 1 in oncogenesis (review).
Jariwala N; Rajasekaran D; Srivastava J; Gredler R; Akiel MA; Robertson CL; Emdad L; Fisher PB; Sarkar D
Int J Oncol; 2015 Feb; 46(2):465-73. PubMed ID: 25405367
[TBL] [Abstract][Full Text] [Related]
2. Staphylococcal Nuclease and Tudor Domain Containing 1 (SND1 Protein) Promotes Hepatocarcinogenesis by Inhibiting Monoglyceride Lipase (MGLL).
Rajasekaran D; Jariwala N; Mendoza RG; Robertson CL; Akiel MA; Dozmorov M; Fisher PB; Sarkar D
J Biol Chem; 2016 May; 291(20):10736-46. PubMed ID: 26997225
[TBL] [Abstract][Full Text] [Related]
3. SND1, a component of RNA-induced silencing complex, is up-regulated in human colon cancers and implicated in early stage colon carcinogenesis.
Tsuchiya N; Ochiai M; Nakashima K; Ubagai T; Sugimura T; Nakagama H
Cancer Res; 2007 Oct; 67(19):9568-76. PubMed ID: 17909068
[TBL] [Abstract][Full Text] [Related]
4. MiR-361-5p inhibits colorectal and gastric cancer growth and metastasis by targeting staphylococcal nuclease domain containing-1.
Ma F; Song H; Guo B; Zhang Y; Zheng Y; Lin C; Wu Y; Guan G; Sha R; Zhou Q; Wang D; Zhou X; Li J; Qiu X
Oncotarget; 2015 Jul; 6(19):17404-16. PubMed ID: 25965817
[TBL] [Abstract][Full Text] [Related]
5. SND1 affects proliferation of hepatocellular carcinoma cell line SMMC-7721 by regulating IGFBP3 expression.
Yin J; Ding J; Huang L; Tian X; Shi X; Zhi L; Song J; Zhang Y; Gao X; Yao Z; Jing X; Yang J
Anat Rec (Hoboken); 2013 Oct; 296(10):1568-75. PubMed ID: 23878061
[TBL] [Abstract][Full Text] [Related]
6. Staphylococcal nuclease domain-containing protein 1 as a potential tissue marker for prostate cancer.
Kuruma H; Kamata Y; Takahashi H; Igarashi K; Kimura T; Miki K; Miki J; Sasaki H; Hayashi N; Egawa S
Am J Pathol; 2009 Jun; 174(6):2044-50. PubMed ID: 19435788
[TBL] [Abstract][Full Text] [Related]
7. Insights Into
Ochoa B; Chico Y; Martínez MJ
Front Oncol; 2018; 8():606. PubMed ID: 30619748
[TBL] [Abstract][Full Text] [Related]
8. Increased RNA-induced silencing complex (RISC) activity contributes to hepatocellular carcinoma.
Yoo BK; Santhekadur PK; Gredler R; Chen D; Emdad L; Bhutia S; Pannell L; Fisher PB; Sarkar D
Hepatology; 2011 May; 53(5):1538-48. PubMed ID: 21520169
[TBL] [Abstract][Full Text] [Related]
9. Correlated overexpression of metadherin and SND1 in glioma cells.
Tong L; Wang C; Hu X; Pang B; Yang Z; He Z; He M; Wei L; Chu M
Biol Chem; 2016 Jan; 397(1):57-65. PubMed ID: 26351803
[TBL] [Abstract][Full Text] [Related]
10. Molecular and cellular insights into the role of SND1 in lipid metabolism.
Navarro-Imaz H; Ochoa B; García-Arcos I; Martínez MJ; Chico Y; Fresnedo O; Rueda Y
Biochim Biophys Acta Mol Cell Biol Lipids; 2020 May; 1865(5):158589. PubMed ID: 31978555
[TBL] [Abstract][Full Text] [Related]
11. SND1 binds to ERG and promotes tumor growth in genetic mouse models of prostate cancer.
Liao SY; Rudoy D; Frank SB; Phan LT; Klezovitch O; Kwan J; Coleman I; Haffner MC; Li D; Nelson PS; Emili A; Vasioukhin V
Nat Commun; 2023 Nov; 14(1):7435. PubMed ID: 37973913
[TBL] [Abstract][Full Text] [Related]
12. SND1 acts as a novel gene transcription activator recognizing the conserved Motif domains of Smad promoters, inducing TGFβ1 response and breast cancer metastasis.
Yu L; Di Y; Xin L; Ren Y; Liu X; Sun X; Zhang W; Yao Z; Yang J
Oncogene; 2017 Jul; 36(27):3903-3914. PubMed ID: 28263968
[TBL] [Abstract][Full Text] [Related]
13. Profiling of promoter occupancy by the SND1 transcriptional coactivator identifies downstream glycerolipid metabolic genes involved in TNFα response in human hepatoma cells.
Arretxe E; Armengol S; Mula S; Chico Y; Ochoa B; Martínez MJ
Nucleic Acids Res; 2015 Dec; 43(22):10673-88. PubMed ID: 26323317
[TBL] [Abstract][Full Text] [Related]
14. The multifaceted oncogene SND1 in cancer: focus on hepatocellular carcinoma.
Chidambaranathan-Reghupaty S; Mendoza R; Fisher PB; Sarkar D
Hepatoma Res; 2018; 4():. PubMed ID: 32258418
[TBL] [Abstract][Full Text] [Related]
15. SND1 overexpression deregulates cholesterol homeostasis in hepatocellular carcinoma.
Navarro-Imaz H; Rueda Y; Fresnedo O
Biochim Biophys Acta; 2016 Sep; 1861(9 Pt A):988-996. PubMed ID: 27238764
[TBL] [Abstract][Full Text] [Related]
16. [Effect of Staphylococcal Nuclease and Tudor Domain Containing 1/SLC7A11 on the Occurrence and Development of Osteosarcoma by Inhibiting Ferroptosis].
Wang ST; Xu SJ; Gui P; Li XN; Sui YH; Li ZX
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2024 Feb; 46(1):11-18. PubMed ID: 38433625
[TBL] [Abstract][Full Text] [Related]
17. Posttranscriptional Inhibition of Protein Tyrosine Phosphatase Nonreceptor Type 23 by Staphylococcal Nuclease and Tudor Domain Containing 1: Implications for Hepatocellular Carcinoma.
Jariwala N; Mendoza RG; Garcia D; Lai Z; Subler MA; Windle JJ; Mukhopadhyay ND; Fisher PB; Chen Y; Sarkar D
Hepatol Commun; 2019 Sep; 3(9):1258-1270. PubMed ID: 31497746
[TBL] [Abstract][Full Text] [Related]
18. MTDH-SND1 interaction is crucial for expansion and activity of tumor-initiating cells in diverse oncogene- and carcinogen-induced mammary tumors.
Wan L; Lu X; Yuan S; Wei Y; Guo F; Shen M; Yuan M; Chakrabarti R; Hua Y; Smith HA; Blanco MA; Chekmareva M; Wu H; Bronson RT; Haffty BG; Xing Y; Kang Y
Cancer Cell; 2014 Jul; 26(1):92-105. PubMed ID: 24981741
[TBL] [Abstract][Full Text] [Related]
19. Loss of the methylarginine reader function of SND1 confers resistance to hepatocellular carcinoma.
Wright T; Wang Y; Stratton SA; Sebastian M; Liu B; Johnson DG; Bedford MT
Biochem J; 2023 Nov; 480(22):1805-1816. PubMed ID: 37905668
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA, SND1, and alterations in translational regulation in colon carcinogenesis.
Tsuchiya N; Nakagama H
Mutat Res; 2010 Nov; 693(1-2):94-100. PubMed ID: 20883704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
